0000899243-19-002657.txt : 20190205
0000899243-19-002657.hdr.sgml : 20190205
20190205173632
ACCESSION NUMBER: 0000899243-19-002657
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190204
FILED AS OF DATE: 20190205
DATE AS OF CHANGE: 20190205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elam Nevan C
CENTRAL INDEX KEY: 0001314773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 19569052
MAIL ADDRESS:
STREET 1: C/O NEKTAR THERAPEUTICS
STREET 2: 150 INDUSTRIAL ROAD
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 512-614-1848
MAIL ADDRESS:
STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-04
0
0001160308
Savara Inc
SVRA
0001314773
Elam Nevan C
6836 BEE CAVE ROAD, BUILDING III
SUITE 200
AUSTIN
TX
78746
1
0
0
0
Common Stock
2019-02-04
4
M
0
21682
0.19
A
21682
D
Stock Option (Right to Buy)
0.19
2019-02-04
4
M
0
21682
0.00
D
2019-02-20
Common Stock
21682
0
D
The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on May 20, 2009. 5,420 shares subject to the option became vested and exercisable on October 22, 2010.
/s/ David Lowrance, David Lowrance as attorney-in-fact for Nevan C. Elam
2019-02-05